BACKGROUND: Advanced age remains one of the principal determinants of mortality in patients with acute myocardial infarction (AMI). HYPOTHESIS: The aim of this study was to determine the in-hospital outcome of elderly (> 75 years) patients with AMI who were admitted to hospitals participating in the national MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry. METHODS: MITRA is a prospective, observational German multicenter registry investigating current treatment modalities for patients presenting with AMI. All patients with AMI admitted within 96 h of onset of symptoms were included in the MITRA registry. MITRA was started in June 1994 and ended in January 1997. This registry comprises 6,067 consecutive patients with a mean age of 65 +/- 12 years, of whom 1,430 (17%) were aged > 75 years. Patients were compared with respect to patient characteristics, prehospital delays, early treatment strategies, and clinical outcome. RESULTS: In the elderly patient population, the prehospital delay was 210 min, which was significantly longer than that for younger patients (155 min, p = 0.001). Although the incidence of potential contraindications for the initiation of thrombolysis was almost equally distributed between the two age groups (8.7 vs. 8.2%, p = NS), elderly patients (> 75 years) received reperfusion therapy less frequently (35.9 vs. 64.6%) than younger patients. Mortality increased with advanced age and was 26.4% for all patients aged > 75 years. If reperfusion therapy was initiated, in-hospital mortality was 21.8 versus 28.9% in patients aged > 75 years (p = 0.001) and 29.4 versus 38.5% in patients aged > 85 years (p = 0.001). CONCLUSION: In this registry, elderly patients with AMI had a much higher in-hospital mortality than that expected from randomized trials. In MITRA, the mortality reduction with reperfusion therapy was found to be highest in the very elderly patient population.
BACKGROUND: Advanced age remains one of the principal determinants of mortality in patients with acute myocardial infarction (AMI). HYPOTHESIS: The aim of this study was to determine the in-hospital outcome of elderly (> 75 years) patients with AMI who were admitted to hospitals participating in the national MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry. METHODS: MITRA is a prospective, observational German multicenter registry investigating current treatment modalities for patients presenting with AMI. All patients with AMI admitted within 96 h of onset of symptoms were included in the MITRA registry. MITRA was started in June 1994 and ended in January 1997. This registry comprises 6,067 consecutive patients with a mean age of 65 +/- 12 years, of whom 1,430 (17%) were aged > 75 years. Patients were compared with respect to patient characteristics, prehospital delays, early treatment strategies, and clinical outcome. RESULTS: In the elderly patient population, the prehospital delay was 210 min, which was significantly longer than that for younger patients (155 min, p = 0.001). Although the incidence of potential contraindications for the initiation of thrombolysis was almost equally distributed between the two age groups (8.7 vs. 8.2%, p = NS), elderly patients (> 75 years) received reperfusion therapy less frequently (35.9 vs. 64.6%) than younger patients. Mortality increased with advanced age and was 26.4% for all patients aged > 75 years. If reperfusion therapy was initiated, in-hospital mortality was 21.8 versus 28.9% in patients aged > 75 years (p = 0.001) and 29.4 versus 38.5% in patients aged > 85 years (p = 0.001). CONCLUSION: In this registry, elderly patients with AMI had a much higher in-hospital mortality than that expected from randomized trials. In MITRA, the mortality reduction with reperfusion therapy was found to be highest in the very elderly patient population.
Authors: A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson Journal: Lancet Date: 1981-10-17 Impact factor: 79.321
Authors: M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker Journal: N Engl J Med Date: 1992-09-03 Impact factor: 91.245
Authors: Milosz Jaguszewski; Jelena-R Ghadri; Johanna Diekmann; Roxana D Bataiosu; Jens P Hellermann; Annahita Sarcon; Asim Siddique; Lukas Baumann; Barbara E Stähli; Thomas F Lüscher; Willibald Maier; Christian Templin Journal: Clin Res Cardiol Date: 2014-08-21 Impact factor: 5.460
Authors: Arne Kristian Schwarz; Ralf Zahn; Matthias Hochadel; Sebastian Kerber; Karl E Hauptmann; Hans-Georg Glunz; Harald Mudra; Harald Darius; Uwe Zeymer Journal: Clin Res Cardiol Date: 2011-04-21 Impact factor: 5.460
Authors: James Samir Díaz-Betancur; Juan Manuel Martínez; Juan Gabriel Zapata; Isabel Marín-Orozco Journal: Aging Clin Exp Res Date: 2020-10-24 Impact factor: 3.636
Authors: Stefan Zimmermann; Susanne Ruthrof; Kathrin Nowak; Lutz Klinghammer; Josef Ludwig; Werner G Daniel; Frank A Flachskampf Journal: Clin Cardiol Date: 2009-02 Impact factor: 2.882
Authors: Baskaran Komarasamy; Mark C Forster; Colin N Esler; William M Harper; Andrew P Hall Journal: Ann R Coll Surg Engl Date: 2007-07 Impact factor: 1.891
Authors: Ajar Kochar; Anita Y Chen; Puza P Sharma; Neha J Pagidipati; Gregg C Fonarow; Patricia A Cowper; Matthew T Roe; Eric D Peterson; Tracy Y Wang Journal: J Am Heart Assoc Date: 2018-06-30 Impact factor: 5.501